HWM
EW icon

Hemington Wealth Management’s Edwards Lifesciences EW Stock Holding History

Hemington Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$51K Sell
656
-7
-1% -$547 0.01% 355
2025
Q2 		$51K Buy
663
+81
+14% +$6.04K 0.01% 337
2025
Q1 		$42K Buy
582
+57
+11% +$4.08K 0.01% 365
2024
Q4 		$38K Buy
525
+53
+11% +$3.71K 0.01% 368
2024
Q3 		$31K Buy
+472
New +$34.3K 0.01% 394

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Hemington Wealth Management's EW Position: Q3 2025 in Review

Hemington Wealth Management reduced its Edwards Lifesciences (EW) stake by 1.1% in Q3 2025, selling an estimated $547 and leaving 656 shares worth $51K. The position accounts for 0.01% of the portfolio, ranked #355.

Hemington Wealth Management first reported a position in EW in Q3 2024 and has held it in 5 quarters since. 1,254 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Hemington Wealth Management held 656 shares of Edwards Lifesciences worth $51K as of Q3 2025.
  • Hemington Wealth Management sold 7 Edwards Lifesciences shares in Q3 2025, an estimated $547.
  • Edwards Lifesciences made up 0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #355 holding.
  • Hemington Wealth Management first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 5 quarters since.
  • 1,254 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.